Abstract
There are some indications that seizure activity promotes the development of stroke-like episodes, or vice versa, in patients with mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome or other syndromic mitochondrial disorders. A 41-year-old Caucasian female with MELAS syndrome, presenting with short stature, microcytic anaemia, increased blood-sedimentation rate, myopathy, hyper-gammaglobulinaemia, an ironmetabolism defect, migraine-like headaches, and stroke-like episodes, developed complex partial and generalised seizures at age 32 years. Valproic acid was ineffective but after switching to lamotrigine and lorazepam, she became seizure-free for five years and stroke-like episodes did not recur. Cerebral MRI initially showed enhanced gyral thickening and a non-enhanced T2-hyperintensity over the left parieto-temporo-occipital white matter and cortex and enhanced caudate heads. After two years without seizures, the non-enhanced hyperintense parieto-temporo-occipital lesion had disappeared, being attributed to consequent seizure control. The caudate heads, however, remained hyperintense throughout the observational period. This case indicates that adequate seizure control in a patient with MELAS syndrome may prevent the recurrence of stroke-like episodes and may result in the disappearance of stroke-like lesions on MRI.
Article PDF
Similar content being viewed by others
References
Deschauer M, Tennant S, Rokicka A, He L, Kraya T, Turnbull DM, et al. MELAS associated with mutations in the POLG1 gene. Neurology 2007; 68: 1741–1742.
Finsterer J, Segall L. Drugs interfering with mitochondrial disorders. Drug Chem Toxicol 2010; 33: 138–151.
Finsterer J. Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation. Acta Neurol Scand 2007; 116: 1–14.
Iizuka T, Sakai F, Kan S, Suzuki N. Slowly progressive spread of the stroke-like lesions in MELAS. Neurology 2003; 61: 1238–1244.
Iizuka T, Sakai F, Suzuki N, Hata T, Tsukahara S, Fukuda M, et al. Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 2002; 59: 816–824.
Ishikawa N, Tajima G, Ono H, Kobayashi M. Different neuroradiological findings during two stroke-like-episodes in a patient with a congenital disorder of glycosylation type Ia. Brain Dev 2009; 31: 240–243.
Ito H, Mori K, Harada M, Minato M, Naito E, Takeuchi M, et al. Serial brain imaging analysis of stroke-like-episodes in MELAS. Brain Dev 2008; 30: 483–488.
Kubota M, Sakakihara Y, Mori M, Yamagata T, Momoi-Yoshida M. Beneficial effect of L-arginine for stroke-like episode in MELAS. Brain Dev 2004; 26: 481–483.
Lin CM, Thajeb P. Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA. Metab Brain Dis 2007; 22: 105–109.
Ohshita T, Oka M, Imon Y, Watanabe C, Katayama S, Yamaguchi S, et al. Serial diffusion-weighted imaging in MELAS. Neuroradiology 2000; 42: 651–656.
Testai FD, Gorelick PB. Inherited metabolic disorders and stroke part 1: Fabry disease and mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Arch Neurol 2010; 67: 19–24.
Toth G, Morava E, Bene J, Selhorst JJ, Overmars H, Vreken P, et al. Carnitine-responsive carnitine insufficiency in a case of mtDNA 8993T>C mutation associated Leigh syndrome. J Inherit Metab Dis 2001; 24: 421–422.
Tzoulis C, Bindoff LA. Serial diffusion imaging in a case of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like-episodes. Stroke 2009; 40: e15–e17.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Finsterer, J., Barton, P. Regression of stroke-like lesions in MELAS-syndrome after seizure control. Epileptic Disord 12, 330–334 (2010). https://doi.org/10.1684/epd.2010.0338
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1684/epd.2010.0338